A combined stem-cell–gene therapy strategy for ALS
Crossref DOI link: https://doi.org/10.1038/s41591-022-01983-0
Published Online: 2022-09-12
Published Print: 2022-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Okano, Hideyuki http://orcid.org/0000-0001-7482-5935
Text and Data Mining valid from 2022-09-01
Version of Record valid from 2022-09-01
Article History
First Online: 12 September 2022
Competing interests
: The author is a founding scientist of SanBio Co. Ltd. and K Pharma Inc.